Your browser doesn't support javascript.
loading
Clinical signs of impending death in cancer patients.
Hui, David; dos Santos, Renata; Chisholm, Gary; Bansal, Swati; Silva, Thiago Buosi; Kilgore, Kelly; Crovador, Camila Souza; Yu, Xiaoying; Swartz, Michael D; Perez-Cruz, Pedro Emilio; Leite, Raphael de Almeida; Nascimento, Maria Salete de Angelis; Reddy, Suresh; Seriaco, Fabiola; Yennu, Sriram; Paiva, Carlos Eduardo; Dev, Rony; Hall, Stacy; Fajardo, Julieta; Bruera, Eduardo.
Afiliação
  • Hui D; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • dos Santos R; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Chisholm G; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Bansal S; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Silva TB; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Kilgore K; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Crovador CS; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Yu X; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Swartz MD; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Perez-Cruz PE; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Leite Rde A; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Nascimento MS; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Reddy S; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Seriaco F; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Yennu S; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Paiva CE; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Dev R; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Hall S; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Fajardo J; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
  • Bruera E; Departments of Palliative Care and Rehabilitation Medicine and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil; Division of Biostatistics, University of Texas Health Science Center at Hou
Oncologist ; 19(6): 681-7, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24760709
ABSTRACT

BACKGROUND:

The physical signs of impending death have not been well characterized in cancer patients. A better understanding of these signs may improve the ability of clinicians to diagnose impending death. We examined the frequency and onset of 10 bedside physical signs and their diagnostic performance for impending death.

METHODS:

We systematically documented 10 physical signs every 12 hours from admission to death or discharge in 357 consecutive patients with advanced cancer admitted to two acute palliative care units. We examined the frequency and median onset of each sign from death backward and calculated their likelihood ratios (LRs) associated with death within 3 days.

RESULTS:

In total, 203 of 357 patients (52 of 151 in the U.S., 151 of 206 in Brazil) died. Decreased level of consciousness, Palliative Performance Scale ≤20%, and dysphagia of liquids appeared at high frequency and >3 days before death and had low specificity (<90%) and positive LR (<5) for impending death. In contrast, apnea periods, Cheyne-Stokes breathing, death rattle, peripheral cyanosis, pulselessness of radial artery, respiration with mandibular movement, and decreased urine output occurred mostly in the last 3 days of life and at lower frequency. Five of these signs had high specificity (>95%) and positive LRs for death within 3 days, including pulselessness of radial artery (positive LR 15.6; 95% confidence interval [CI] 13.7-17.4), respiration with mandibular movement (positive LR 10; 95% CI 9.1-10.9), decreased urine output (positive LR 15.2; 95% CI 13.4-17.1), Cheyne-Stokes breathing (positive LR 12.4; 95% CI 10.8-13.9), and death rattle (positive LR 9; 95% CI 8.1-9.8).

CONCLUSION:

We identified highly specific physical signs associated with death within 3 days among cancer patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exame Físico / Morte / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exame Físico / Morte / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article